drugset / Trial / NCT02696616
Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers
RandomizedParallel-groupSingle-blindTreatment
Summary
Investigation of safety and tolerability of BI 655088 following intravenous infusion of single rising doses and exploration of the pharmacokinetics and pharmacodynamics of BI 655088 after single dosing
Timeline
- Start
- 2016-03-16
- Primary completion
- 2019-02-14
- Completion
- 2019-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 655088 | Unknown | — | Intravenous |
Indications
No indication recorded.